Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
325 Leser
Artikel bewerten:
(2)

IPG Health expands Influencer ID marketing expertise into Europe

Strategic rollout will scale US success into key European markets, strengthening the network's leadership of social media strategy in the health/pharma sector

LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- IPG Health is formally extending its specialist Influencer ID offering into Europe, cementing its ability to amplify trustworthy brand voices using the power of social media influencers. Following success in the US and due to growing demand in the region, the network's specialist influencer marketing solution will now be available to clients in the UK, Germany, France and Spain.

Through authentic voices, Influencer ID not only drives brand engagement and combats misinformation but also builds trust, fosters community and amplifies science-backed information for audiences across social media. With increasing numbers seeking health-related information online, influencer marketing continues to gain traction for health brands looking to tap into loyal followings with credibility. It perfectly supports IPG Health's goal to not only deliver brand growth for its clients but also improve health outcomes for patients.

Underpinned by IPG Health's proprietary EPICC suite of tools, Influencer ID ensures gold standard customer engagement and social media strategies are brought to life using patient, caregiver, healthcare provider (HCP) and digital opinion leader (DOL) influencers.

"For many health and pharma brands, having a robust influencer strategy is no longer optional - it's a strategic imperative. We're uniquely placed to help our clients cut through in the online space by tailoring strategies and aligning influencers with a brand's goals while taking into account the varied healthcare systems, regulations and cultural specifities of our region." said Jörg Hempelmann, President, IPG Health EMEA & APAC.

"In a dynamic market like the UK, where more than 80% of healthcare professionals are actively tapping into digital platforms and social media to share knowledge, network with peers, and stay on the cutting edge of industry trends, we're ready to deliver tailored solutions that leverage our deep understanding of the local market and culture. This is crucial for engaging with audiences in a way that's not only compliant but truly impactful and relevant." added Shenga Lushugurhi, Senior Engagement Strategist at FCB Health London.

Fully compliant with evolving regulations, including the European Union's General Data Protection Regulation (GDPR), EFPIA (European Federation of Pharmaceutical Industries and Associations), the British Data Protection Act 2018 and ABPI (Association of the British Pharmaceutical Industry), Influencer ID provides end-to-end services including:

  • Strategic influencer identification and vetting (mega to nano)
  • Engagement and contracting
  • Content development and localization
  • Regulatory and compliance support (including GDPR)
  • Performance analytics and optimization

The extension of IPG Health's Influencer ID into Europe follows the arrival of Annie Foster, Group Director of Social Media Creative, who joins IPG Health from Meta and brings a wealth of experience in the health and beauty sectors. She works alongside global lead Casey Ross, formerly of LinkedIn, to drive greater global interconnectivity across agencies and platforms.

About IPG Health

IPG Health is a global collective of the world's most celebrated and awarded healthcare marketing agencies. We are nearly 6,000 people across six continents driven by a healthy obsession with creating novel marketing solutions, and harnessing creativity, technology, science, and data to inspire behaviors that fuel better health.

With 50+ agencies, including 18+ specialized units, our integrated approach to the full range of communications capabilities ensures we can help clients improve outcomes and quality of life for healthcare audiences around the world. Our clients include the top 20 global pharmaceutical companies as well as countless startups, biotech companies, biopharma companies and a variety of life science companies.

IPG Health companies have earned coveted accolades including Network of the Year at the 2025 Clio Health Awards and Cannes Lions for the third time and fifth year in a row, respectively. In 2024 and 2023 IPG Health achieved "Healthcare Network of the Year" at Ad Age A-List, New York Festivals Health Awards, MM+M Awards, Manny Awards and London International Awards. We are part of the Interpublic Group of Companiesto learn more.

Louise Ringrose
louise.ringrose@ipghealth.com


© 2025 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.